Published June 25, 2019 | Version v1
Journal article Open

The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD)

Description

The results leading to this publication have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777394 for the project AIMS-2-TRIALS. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and AUTISM SPEAKS, Autistica, SFARI. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. Any views expressed are those of the author(s) and not necessarily those of the funders

Files

0269881119858306.pdf

Files (404.4 kB)

Name Size Download all
md5:2597044ed9430b4ff1152f9471eadd3a
404.4 kB Preview Download

Additional details

Funding

European Commission
AIMS-2-TRIALS - Autism Innovative Medicine Studies – 2 – Trials 777394